Valuation: Inogen, Inc.

Market Cap 178M 158M 146M 133M 250M 16.75B 253M 1.76B 689M 8.81B 666M 652M 28.06B P/E 2026 *
-8.75x
P/E 2027 * -14.1x
Enterprise Value 178M 158M 146M 133M 250M 16.75B 253M 1.76B 689M 8.81B 666M 652M 28.06B EV / Sales 2026 *
0.5x
EV / Sales 2027 * 0.48x
Free-Float
87.05%
Yield 2026 *
-
Yield 2027 * -
1 day-0.45%
1 week+8.48%
Current month+26.19%
1 month+30.39%
3 months+3.42%
6 months-4.45%
Current year-1.04%
1 week 6.2
Extreme 6.2
6.79
1 month 5.04
Extreme 5.045
6.79
Current year 5.04
Extreme 5.045
7.67
1 year 5.04
Extreme 5.045
9.13
3 years 4.13
Extreme 4.13
13.33
5 years 4.13
Extreme 4.13
41.83
10 years 4.13
Extreme 4.13
287.79
Manager TitleAgeSince
Chief Executive Officer 55 2023-11-09
Director of Finance/CFO 48 2026-04-05
Chief Operating Officer 56 2026-07-05
Director TitleAgeSince
Director/Board Member 66 2014-08-05
Chairman 65 2021-12-28
Director/Board Member 59 2022-03-21
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Free

Controller/Auditor

1,500 0.0057%
9/1/26 Free

General Counsel

46,443 0.1750%
9/1/26 Free

Chief Executive Officer

1,500 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-0.37%+8.48%-21.67%+50.11% 178M
-2.60%-3.82%-22.35%+3.40% 177B
-2.54%+4.96%-22.16%+12.15% 117B
-1.76%-1.50%-3.14%+28.22% 116B
+15.48%+17.35%-45.10%+5.02% 77.71B
-0.78%+1.32%+3.58%+80.38% 65.51B
+1.98%+4.70%+17.36%+81.35% 54.97B
+0.29%+2.88%+2.80%-24.07% 52.79B
-0.71%+5.06%-12.77%+29.94% 43.95B
-6.01%-3.20%+15.84%-6.07% 32.35B
Average +0.32%+3.58%-8.76%+26.04% 73.73B
Weighted average by Cap. +0.08%+3.03%-12.39%+20.72%

Financials

2026 *2027 *
Net sales 356M 318M 294M 266M 501M 33.63B 507M 3.53B 1.38B 17.68B 1.34B 1.31B 56.33B 373M 332M 307M 278M 524M 35.16B 530M 3.69B 1.45B 18.48B 1.4B 1.37B 58.89B
Net income -20.8M -18.53M -17.16M -15.53M -29.26M -1.96B -29.6M -206M -80.73M -1.03B -78.03M -76.4M -3.29B -13.35M -11.9M -11.01M -9.97M -18.78M -1.26B -19M -132M -51.82M -662M -50.08M -49.04M -2.11B
Net Debt - -
Projected Income Statement - Annual - Inogen, Inc.
Logo Inogen, Inc.
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Employees
753
Date Price Change Volume
26-10-21 US$6.670 -0.30% 125,473
26-10-20 US$6.690 +2.14% 229,027
26-10-19 US$6.550 +4.80% 235,192
26-10-16 US$6.250 -0.71% 193,861
26-10-15 US$6.295 +2.69% 161,059
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - Inogen, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.690USD
Average target price
12.00USD
Spread / Average Target
+79.37%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Inogen, Inc.
  1. Stock Market
  2. Stocks
  3. INGN Stock